Concord Drugs Complete Financial Statements
CONCORD • Review detailed financials to uncover trends, confirm thesis & journal trades
4 Years of Data
2025 - 2022
Complete Financial Data Export
Export complete financial statements for Concord Drugs (CONCORD).
Downloads include all available records across all periods.
For market performance, see the
CONCORD stock price today
.
Profitability Ratios
EBITDA Margin
10.00%
2025 data
Operating Margin
11.00%
2025 data
Balance Sheet Ratios
Current Ratio
8.20
2025 data
Debt to Equity
1.91
2025 data
Equity Ratio
52.31%
2025 data
Asset Turnover
0.15
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
-16.7%
Year-over-Year
Expense Growth
-25.0%
Year-over-Year
Assets Growth
+10.2%
Year-over-Year
Liabilities Growth
+10.2%
Year-over-Year
Operating Cash Flow Growth
+300.0%
Year-over-Year
Investing Cash Flow Growth
-100.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10 | 10 | 14 | 12 | 16 | 12 | 11 | 8 | 12 | 9 | 13 | 14 | 16 | 13 | 14 |
| Expenses | 9 | 9 | 13 | 12 | 15 | 11 | 9 | 6 | 11 | 8 | 12 | 13 | 15 | 12 | 12 |
| EBITDA | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 1 |
| Operating Profit Margin % | 11.00% | 10.00% | 7.00% | 7.00% | 2.00% | 7.00% | 13.00% | 21.00% | 8.00% | 16.00% | 5.00% | 9.00% | 4.00% | 8.00% | 11.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Interest | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 0 | -1 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Earnings Per Share (₹) | 0.19 | 0.04 | 0.12 | 0.04 | -0.34 | 0.03 | 0.23 | 0.60 | 0.17 | 0.53 | -0.24 | 0.21 | 0.03 | 0.21 | 0.52 |
Related Pages for Concord Drugs
Additional stock information and data for CONCORD
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| Total Assets | 65 | 59 | 58 | 56 |
| Current Assets | 41 | 38 | 44 | 42 |
| Fixed Assets | 12 | 12 | 13 | 14 |
| Capital Work in Progress | 2 | 2 | 1 | 1 |
| Investments | 1 | 1 | 1 | 0 |
| Other Assets | 50 | 45 | 44 | 42 |
| LIABILITIES | ||||
| Total Liabilities | 65 | 59 | 58 | 56 |
| Current Liabilities | 5 | 4 | 5 | 4 |
| Non-Current Liabilities | ||||
| SHAREHOLDERS' EQUITY | ||||
| Total Equity | 34 | 34 | 32 | 28 |
| Share Capital | 10 | 10 | 9 | 9 |
| Reserves & Surplus | 24 | 24 | 22 | 20 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 |
|---|---|---|---|---|
| Operating Activities | 4 | 1 | 2 | 1 |
| Investing Activities | -2 | -1 | -2 | -2 |
| Financing Activities | -1 | 0 | 1 | 2 |
| Net Cash Flow | 0 | 0 | 0 | 0 |